231 related articles for article (PubMed ID: 2659861)
1. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
Koda H; Hashimoto T; Kuriyama K
Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
Hashimoto T; Katsura M; Kuriyama K
Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
Koda H; Hashimoto T; Kuriyama K
Eur J Pharmacol; 1989 Mar; 162(3):501-8. PubMed ID: 2744083
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
Dawson VL; Dawson TM; Wamsley JK
Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
[TBL] [Abstract][Full Text] [Related]
5. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
Leung TK; Lai JC; Lim L
Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
[TBL] [Abstract][Full Text] [Related]
6. Effect of buflomedil [4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone hydrochloride] on neurotransmitters in the striatum and substantia nigra.
Koda H; Hashimoto T; Kuriyama K
Jpn J Pharmacol; 1988 Jul; 47(3):253-9. PubMed ID: 2906099
[TBL] [Abstract][Full Text] [Related]
7. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
Zetterström T; Sharp T; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
Hietala J; Syvälahti E; Röyttä M
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
10. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
Sanvarinda Y; Phivthongngam L; Govitrapong P
Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
[TBL] [Abstract][Full Text] [Related]
11. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum.
Akiyama K; Sato M; Yamada N; Otsuki S
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):311-20. PubMed ID: 2830427
[TBL] [Abstract][Full Text] [Related]
13. Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain.
Kajiyama H; Nomura Y
J Pharmacobiodyn; 1981 Feb; 4(2):85-90. PubMed ID: 7196947
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
Syvälahti EK; Hietala J; Röyttä M; Grönroos J
Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
[TBL] [Abstract][Full Text] [Related]
15. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
16. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
17. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain.
Lim DK; Ito Y; Hoskins B; Ho IK
Brain Res Bull; 1988 Jul; 21(1):21-4. PubMed ID: 3064880
[TBL] [Abstract][Full Text] [Related]
19. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
Joyce JN
Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat.
Bhargava HN
Toxicol Lett; 1987 Jul; 37(2):135-41. PubMed ID: 3603588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
